| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 高血压类药(元) | 169,166,642.31 | 255,001,063.27 | 133,496,462.56 | 205,242,761.41 | 102,779,572.49 |
| 罕见病类药(元) | 3,585,014.31 | 3,602,291.84 | 1,468,161.90 | 1,558,190.41 | 708,213.02 |
| 泌尿系统类(元) | 478,852.55 | 555,622.93 | 268,287.22 | 421,383.16 | 245,313.52 |
| 糖尿病类药(元) | 348,004,902.01 | 603,128,865.02 | 294,195,516.07 | 499,341,715.25 | 257,502,787.18 |
| 周围神经类药(元) | 2,687,912.40 | 6,106,716.50 | 3,052,984.48 | 2,643,704.51 | 1,130,872.20 |
| 风湿免疫类(元) | 574,942.26 | 70,034.00 | 393.63 | - | - |
| 高血脂类(元) | 50,536.27 | - | - | - | - |
| 营业成本(元) | |||||
| 高血压类药(元) | 6,818,506.14 | 11,756,733.25 | 6,405,456.51 | 13,021,643.20 | 6,884,515.78 |
| 罕见病类药(元) | 317,598.67 | 413,818.18 | 60,296.37 | 50,689.91 | 20,774.12 |
| 泌尿系统类(元) | 94,350.77 | 140,568.40 | 64,240.31 | 89,371.40 | 43,615.80 |
| 糖尿病类药(元) | 76,521,640.21 | 119,589,862.01 | 59,024,757.45 | 114,146,850.26 | 57,047,850.05 |
| 周围神经类药(元) | 925,035.60 | 2,166,164.90 | 1,107,636.94 | 1,269,940.53 | 565,314.77 |
| 风湿免疫类(元) | 124,534.18 | 11,212.18 | 19.98 | - | - |
| 高血脂类(元) | 9,103.86 | - | - | - | - |
| 毛利(元) | |||||
| 高血压类药(元) | 162,348,136.17 | 243,244,330.02 | 127,091,006.05 | 192,221,118.21 | 95,895,056.71 |
| 罕见病类药(元) | 3,267,415.64 | 3,188,473.66 | 1,407,865.53 | 1,507,500.50 | 687,438.90 |
| 泌尿系统类(元) | 384,501.78 | 415,054.53 | 204,046.91 | 332,011.76 | 201,697.72 |
| 糖尿病类药(元) | 271,483,261.80 | 483,539,003.01 | 235,170,758.62 | 385,194,864.99 | 200,454,937.13 |
| 周围神经类药(元) | 1,762,876.80 | 3,940,551.60 | 1,945,347.54 | 1,373,763.98 | 565,557.43 |
| 风湿免疫类(元) | 450,408.08 | 58,821.82 | 373.65 | - | - |
| 高血脂类(元) | 41,432.41 | - | - | - | - |
| 毛利率(%) | |||||
| 高血压类药(%) | 95.97 | 95.39 | 95.20 | 93.66 | 93.30 |
| 罕见病类药(%) | 91.14 | 88.51 | 95.89 | 96.75 | 97.07 |
| 泌尿系统类(%) | 80.30 | 74.70 | 76.06 | 78.79 | 82.22 |
| 糖尿病类药(%) | 78.01 | 80.17 | 79.94 | 77.14 | 77.85 |
| 周围神经类药(%) | 65.59 | 64.53 | 63.72 | 51.96 | 50.01 |
| 风湿免疫类(%) | 78.34 | 83.99 | 94.92 | - | - |
| 高血脂类(%) | 81.99 | - | - | - | - |
| 收入构成(%) | |||||
| 高血压类药(%) | 32.25 | 29.36 | 30.87 | 28.94 | 28.36 |
| 罕见病类药(%) | 0.68 | 0.41 | 0.34 | 0.22 | 0.20 |
| 泌尿系统类(%) | 0.09 | 0.06 | 0.06 | 0.06 | 0.07 |
| 糖尿病类药(%) | 66.34 | 69.45 | 68.02 | 70.41 | 71.06 |
| 周围神经类药(%) | 0.51 | 0.70 | 0.71 | 0.37 | 0.31 |
| 风湿免疫类(%) | 0.11 | 0.01 | 0.00 | - | - |
| 高血脂类(%) | 0.01 | - | - | - | - |
| 毛利构成(%) | |||||
| 高血压类药(%) | 36.92 | 33.12 | 34.74 | 33.11 | 32.20 |
| 罕见病类药(%) | 0.74 | 0.43 | 0.38 | 0.26 | 0.23 |
| 泌尿系统类(%) | 0.09 | 0.06 | 0.06 | 0.06 | 0.07 |
| 糖尿病类药(%) | 61.74 | 65.84 | 64.29 | 66.34 | 67.31 |
| 周围神经类药(%) | 0.40 | 0.54 | 0.53 | 0.24 | 0.19 |
| 风湿免疫类(%) | 0.10 | 0.01 | 0.00 | - | - |
| 高血脂类(%) | 0.01 | - | - | - | - |